Literature DB >> 21979562

A novel mutation and unusual clinical features in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome.

Keun Wook Bae1, Bo Eun Kim, Jin-Ho Choi, Joo Hoon Lee, Young Seo Park, Gu-Hwan Kim, Han Wook Yoo, Jong Jin Seo.   

Abstract

UNLABELLED: We report a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome with a novel splicing mutation of the FOXP3 gene. The patient is a boy, born at 39 + 2 weeks gestation with a birth weight of 3,280 g. The family history was unremarkable. He was well until 11 months of age, when he was diagnosed with type 1 diabetes mellitus. The level of urine C-peptide was 0.58 μg/day (normal range, 44-116 μg/day). Glutamic acid decarboxylase autoantibody was not detected, but a high level of anti-insulin antibody (50 IU/mL; normal range, <5 IU/mL) was noted. This patient presented with unusual clinical features, including pure red cell aplasia, membranous glomerulopathy, and posterior reversible encephalopathy syndrome after a vaccination against influenza A H1N1 virus. The diagnosis of IPEX was made when the patient was 11 years old, which is quite late compared with typical cases.
CONCLUSION: Although IPEX syndrome is usually a disease of infancy, it should not be ruled out solely on the basis of age. IPEX presentation is so variable that it should be suspected in a male child with one or more autoimmune disorders and severe infections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21979562     DOI: 10.1007/s00431-011-1588-1

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  26 in total

Review 1.  Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed.

Authors:  V L Stott; M A Hurrell; T J Anderson
Journal:  Intern Med J       Date:  2005-02       Impact factor: 2.048

2.  A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA-->AAUGAA) leads to the IPEX syndrome.

Authors:  C L Bennett; M E Brunkow; F Ramsdell; K C O'Briant; Q Zhu; R L Fuleihan; A O Shigeoka; H D Ochs; P F Chance
Journal:  Immunogenetics       Date:  2001-08       Impact factor: 2.846

3.  Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning.

Authors:  Aarati Rao; Naynesh Kamani; Alexandra Filipovich; Susan Molleran Lee; Stella M Davies; Jignesh Dalal; Shalini Shenoy
Journal:  Blood       Date:  2006-09-21       Impact factor: 22.113

4.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.

Authors:  C L Bennett; J Christie; F Ramsdell; M E Brunkow; P J Ferguson; L Whitesell; T E Kelly; F T Saulsbury; P F Chance; H D Ochs
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

5.  Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX).

Authors:  I Kobayashi; R Shiari; M Yamada; N Kawamura; M Okano; A Yara; A Iguchi; N Ishikawa; T Ariga; Y Sakiyama; H D Ochs; K Kobayashi
Journal:  J Med Genet       Date:  2001-12       Impact factor: 6.318

Review 6.  Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.

Authors:  R S Wildin; S Smyk-Pearson; A H Filipovich
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

7.  Immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: an unusual cause of proteinuria in infancy.

Authors:  Asha Moudgil; Paige Perriello; Brett Loechelt; Ronald Przygodzki; Wendy Fitzerald; Naynesh Kamani
Journal:  Pediatr Nephrol       Date:  2007-07-13       Impact factor: 3.714

8.  A new case of IPEX receiving bone marrow transplantation.

Authors:  E Mazzolari; C Forino; M Fontana; C D'Ippolito; A Lanfranchi; E Gambineri; H Ochs; R Badolato; L D Notarangelo
Journal:  Bone Marrow Transplant       Date:  2005-05       Impact factor: 5.483

9.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.

Authors:  R S Wildin; F Ramsdell; J Peake; F Faravelli; J L Casanova; N Buist; E Levy-Lahad; M Mazzella; O Goulet; L Perroni; F D Bricarelli; G Byrne; M McEuen; S Proll; M Appleby; M E Brunkow
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

10.  Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes.

Authors:  Oscar Rubio-Cabezas; Jayne A L Minton; Richard Caswell; Julian P Shield; Dorothee Deiss; Zdenek Sumnik; Amely Cayssials; Mathias Herr; Anja Loew; Vaughan Lewis; Sian Ellard; Andrew T Hattersley
Journal:  Diabetes Care       Date:  2008-10-17       Impact factor: 17.152

View more
  7 in total

1.  Etiologic distribution and clinical characteristics of pediatric diabetes in 276 children and adolescents with diabetes at a single academic center.

Authors:  Ja Hye Kim; Yena Lee; Yunha Choi; Gu-Hwan Kim; Han-Wook Yoo; Jin-Ho Choi
Journal:  BMC Pediatr       Date:  2021-03-04       Impact factor: 2.125

2.  Clinical Case of Immune Dysregulation, Polyendocrinopaty, Enteropathy, X-Linked (IPEX) Syndrome with Severe Immune Deficiency and Late Onset of Endocrinopathy and Enteropathy.

Authors:  R Savova; M Arshinkova; J Houghton; M Konstantinova; M Gaydarova; E Georgieva; G Popova; V Genova; N Tomova; A Anadoliiska; K Koprivarova
Journal:  Case Rep Med       Date:  2014-06-01

3.  Clinical and immunological characteristics of five patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome in China-expanding the atypical phenotypes.

Authors:  Yu Huang; Shuyu Fang; Ting Zeng; Junjie Chen; Lu Yang; Gan Sun; Rongxin Dai; Yunfei An; Xuemei Tang; Ying Dou; Xiaodong Zhao; Lina Zhou
Journal:  Front Immunol       Date:  2022-08-24       Impact factor: 8.786

Review 4.  Familial Clustering of Juvenile Psoriatic Arthritis Associated with a Hemizygous FOXP3 Mutation.

Authors:  Raed Alzyoud; Shahad Alansari; Heba Maaitah; Haya AlDossari; Dorota Monies; Sulaiman M Al-Mayouf
Journal:  Curr Rheumatol Rep       Date:  2021-07-03       Impact factor: 4.592

5.  Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity.

Authors:  Federica Barzaghi; Laura Passerini; Rosa Bacchetta
Journal:  Front Immunol       Date:  2012-07-31       Impact factor: 7.561

Review 6.  The contribution of thymic tolerance to central nervous system autoimmunity.

Authors:  Piero Alberti; Adam E Handel
Journal:  Semin Immunopathol       Date:  2020-10-27       Impact factor: 9.623

7.  Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked Syndrome in Two Siblings: Same Mutation But Different Clinical Manifestations at Onset

Authors:  Gülay Karagüzel; Recep Polat; Mehtap H Abul; Alper Han Cebi; Fazıl Orhan
Journal:  J Clin Res Pediatr Endocrinol       Date:  2021-05-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.